This study is looking at whether Trimethoprim Tablets, a drug taken once daily for 3 months, is a safe and effective way to lower folate levels in men with advanced prostate cancer who are also receiving Androgen Deprivation Therapy (ADT). Researchers want to understand the good and bad effects of Trimethoprim and how it impacts the disease. The study aims to enroll 50 men aged 18 or older who have a proven diagnosis of prostate cancer. The main goal is to check the safety of Trimethoprim. This study is currently unclear about its recruitment status.

Study design

This is an interventional study planning to enroll 50 participants. The phase of the study is not specified.

What's involved

You will attend approximately 4 to 7 visits, depending on your assigned group. These research procedures will be done during your routine hospital/clinic visits, which may be every 1-3 months. You will need to stop taking any supplements or medications with folic acid or potassium before joining.

Compensation

Not stated in the trial record.

Follow-up

Safety will be measured from the first dose through 1 month after you finish study therapy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.